X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (82) 82
index medicus (76) 76
female (38) 38
male (34) 34
peripheral vascular disease (33) 33
middle aged (32) 32
cardiovascular (30) 30
endocrinology & metabolism (29) 29
risk factors (25) 25
cardiac & cardiovascular systems (23) 23
cardiovascular disease (22) 22
diabetes (22) 22
adult (21) 21
lipids (20) 20
treatment outcome (20) 20
coronary-heart-disease (19) 19
hypercholesterolemia (19) 19
aged (18) 18
biochemistry & molecular biology (16) 16
low density lipoproteins (16) 16
abridged index medicus (15) 15
cholesterol (15) 15
statins (15) 15
cardiovascular-disease (14) 14
medicine, general & internal (14) 14
risk (14) 14
cholesterol, ldl - blood (13) 13
cardiovascular diseases - prevention & control (12) 12
lipoproteins (12) 12
pharmacology & pharmacy (12) 12
research (12) 12
animals (11) 11
anticholesteremic agents - therapeutic use (11) 11
atherosclerosis (11) 11
diabetes mellitus (11) 11
genetic aspects (11) 11
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (11) 11
prevalence (11) 11
cardiology and cardiovascular medicine (10) 10
cardiovascular diseases (10) 10
cardiovascular risk (10) 10
care and treatment (10) 10
density-lipoprotein cholesterol (10) 10
diagnosis (10) 10
disease (10) 10
high-density-lipoprotein (10) 10
therapy (10) 10
association (9) 9
familial hypercholesterolaemia (9) 9
glycation (9) 9
hyperlipoproteinemia type ii - genetics (9) 9
internal medicine (9) 9
low density lipoprotein (9) 9
low-density-lipoprotein (9) 9
mutation (9) 9
obesity (9) 9
analysis (8) 8
apolipoprotein-a-i (8) 8
apolipoprotein-b (8) 8
article (8) 8
coronary artery disease (8) 8
double-blind (8) 8
hdl (8) 8
hypercholesterolemia - drug therapy (8) 8
medicine (8) 8
metaanalysis (8) 8
safety (8) 8
clinical trials (7) 7
double-blind method (7) 7
familial hypercholesterolemia (7) 7
heart-disease (7) 7
ldl (7) 7
management (7) 7
metabolism (7) 7
monoclonal-antibody (7) 7
mortality (7) 7
patients (7) 7
placebo-controlled trial (7) 7
plasma (7) 7
statin therapy (7) 7
atherosclerosis - metabolism (6) 6
cardiovascular risk-factors (6) 6
diabetes mellitus, type 2 - drug therapy (6) 6
drug therapy, combination (6) 6
health aspects (6) 6
heart diseases (6) 6
hyperlipoproteinemia type ii - diagnosis (6) 6
hypoglycemic agents - therapeutic use (6) 6
inflammation (6) 6
ldl cholesterol (6) 6
medical research (6) 6
number needed to treat (6) 6
nutritional and metabolic diseases (6) 6
pcsk9 (6) 6
population (6) 6
statin (6) 6
adolescent (5) 5
antibodies, monoclonal - therapeutic use (5) 5
anticholesteremic agents - adverse effects (5) 5
apolipoproteins (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Atherosclerosis, ISSN 0021-9150, 2014, Volume 236, Issue 2, pp. e304 - e304
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2012, Volume 7, Issue 11, p. e49006
Objectives: Mipomersen, an antisense oligonucleotide targeting apolipoprotein B synthesis, significantly reduces LDL-C and other atherogenic lipoproteins in... 
INTERNATIONAL REFERENCE MATERIAL | LDL CHOLESTEROL | EFFICACY | STATIN THERAPY | MULTIDISCIPLINARY SCIENCES | HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA | B SYNTHESIS INHIBITOR | DOUBLE-BLIND | CARDIOVASCULAR RISK | CHEMISTRY STANDARDIZATION PROJECT | APOLIPOPROTEIN-A-I | Oligodeoxyribonucleotides, Antisense - administration & dosage | Oligonucleotides - therapeutic use | Humans | Oligodeoxyribonucleotides, Antisense - therapeutic use | Male | Oligonucleotides - adverse effects | Treatment Outcome | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Anticholesteremic Agents - therapeutic use | Anticholesteremic Agents - administration & dosage | Oligodeoxyribonucleotides, Antisense - adverse effects | Cholesterol, LDL - blood | Female | Oligonucleotides - administration & dosage | Care and treatment | Hypercholesterolemia | Low density lipoproteins | Anticholesteremic agents | Clinical trials | Aspartate | Research | Blood lipids | Apolipoproteins | Coronary heart disease | Lipoprotein A | Cardiovascular agents | Heart | Lipoproteins (low density) | Therapy | Schedules | Apheresis | Transaminase | Liver | Lipids | Apolipoprotein B | Reduction | Randomization | Fatty liver | Atherosclerosis | Aspartate transaminase | Cardiology | Heart diseases | Drug dosages | Lipoproteins (high density) | Statins | Alanine | Statistical analysis | Reference materials | Antisense oligonucleotides | Pharmacology | Preventive medicine | Patients | Low density lipoprotein | Cholesterol | Steatosis | Side effects | Lipoproteins | Alanine transaminase | Diabetes
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2017, Volume 376, Issue 16, pp. 1527 - 1539
Journal Article
Journal Article